| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:447943150:1761 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:447943150:1761?format=raw |
LEADER: 01761cam a2200385 i 4500
001 3904991
005 20221026235303.0
008 811202t19771977dcua b 001 0 eng
010 $a 77081663
020 $a0917330161
035 $a(OCoLC)3480607
035 $a(OCoLC)ocm03480607
035 $a(CStRLIN)NYCG81-B2237
035 $9AAF9647HS
035 $a(NNC)3904991
035 $a3904991
040 $dNNC-M
050 00 $aRS403$b.D47
082 0 $a615/.19
245 00 $aDesign of biopharmaceutical properties through prodrugs and analogs :$b[a symposium /$csponsored by Medicinal Chemistry Section, APhA Academy of Pharmaceutical Sciences, November 1976 national meeting, Orlando, Florida] ; Edward B. Roche, editor.
260 $aWashington :$bThe Academy,$c[1977], ©1977.
300 $aviii, 455 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
650 0 $aPharmaceutical chemistry.$0http://id.loc.gov/authorities/subjects/sh85023026
650 0 $aBiopharmaceutics.$0http://id.loc.gov/authorities/subjects/sh85014252
650 0 $aDrugs.$0http://id.loc.gov/authorities/subjects/sh85039719
650 2 $aBiopharmaceutics.$0https://id.nlm.nih.gov/mesh/D001702
650 2 $aChemistry, Pharmaceutical.$0https://id.nlm.nih.gov/mesh/D002626
650 2 $aPharmaceutical Preparations.$0https://id.nlm.nih.gov/mesh/D004364
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aRoche, Edward B.$0http://id.loc.gov/authorities/names/n77010079
710 2 $aAcademy of Pharmaceutical Sciences.$bMedicinal Chemistry Section.$0http://id.loc.gov/authorities/names/n77010076
852 00 $boff,hsl$hRS403$iD46 1977